跳至主要内容
临床试验/NCT06704802
NCT06704802已完成不适用

Observational Cohort Study Evaluating the Effectiveness of an Education Program (NGAYDAUTIEN) in Combination With Gliclazide MR in the Management of Uncontrolled Type 2 Diabetic Patients.

Servier Affaires Médicales1 个研究点 分布在 1 个国家目标入组 678 人开始时间: 2022年11月4日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
678
试验地点
1
主要终点
change of HbA1c level (measured in %) from baseline after a 6-month follow-up among the 2 arms

研究概览

简要总结

The primary objective is to assess the change of HbA1c level from baseline after a 6-month follow up among uncontrolled patients with T2D who will be initiated to Diamicron® MR 60 (originator product) plus an educational program (NGAYDAUTIEN) as monotherapy or in add on to metformin in comparison to an initiation of an Oral Antidiabetic Drug (OAD) (except Diamicron®) as monotherapy or in add on to metformin.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Aged at least 18 years (without upper limit of age)
  • HbA1c value is required at the baseline visit
  • Patients with diagnosis of uncontrolled T2D
  • Initiation of a new OAD as monotherapy or on top of metformin
  • Patient follow-up within the scope of the current medical practice and in the same health center during the 6-month period.

排除标准

  • Diagnosis of diabetes other than T2D
  • HbA1c value not available at baseline
  • Patients who previously attended to the NDT educational program for T2D management
  • Required at baseline an insulin therapy according to national guideline
  • Used any other OAD (except metformin)
  • Used a single pill combination in addition to the medicine of interest
  • Have a severe disease (i.e. cirrhosis, end stage renal disease...)
  • Are unlikely to cooperate in the study or to follow the educational program

结局指标

主要结局

change of HbA1c level (measured in %) from baseline after a 6-month follow-up among the 2 arms

时间窗: from baseline to 6-month follow-up

次要结局

未报告次要终点

研究者

发起方
Servier Affaires Médicales
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验